Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any more "tranches?" Hoping a few more would push the volume to over a thousand shares traded.
All those tranches and IPIX is buried in the trenches. Go figure.
From almost $5 a share to a penny a share, the company is quickly running out of funds to pay the salaries of the CEO and his sidekick, has had two of its three prized pipeline drugs abandoned, and has a third drug that has clearly not lived up to the hype, highlighted by its Covid failure. In addition, what is left of this ghost town company is basically a one-man operation and that man is a blundering shell of his pre-2015 self.
All those gripping pieces of enlightenment from 2014 through 2023 and yet the price of IPIX shares is in the penny range with so little market volume. How could this be???
Will these upcoming press releases be as market moving as the past hundred or so?
Wow. With all those "investors" buying shares to reduce their cost basis after being seduced by the hype and grabbing shares at higher prices and apparently awaiting some mythical lucrative partnership, one would think the share price would not be stuck in the penny range. Is the "off-the-chart" volume likewise indicative of Brilacidin's "worldwide awareness?"
Sounds like Ehrlich when the money runs out and there is no money left for the annual salary.
Try again and tell them you are considering investing $4 million in their laser box. That should be the bait to warrant a callback.
Dead or alive, Ehrlich would do the same amount of work and get paid an annual salary.
Word must be getting out about all those Brilacidin pieces being referred to given the amazing IPIX volume of 1000 shares.
Offsetting capital gains is what IPIX is good for....
Ehrlich is running out of money and IPIX shares are clearly not desirable. So unless there is some partnership, licensing deal, or some source of income, the Boca Roton Blunderer may have to shut this dump down.
"The Penicillin of the 21st Century." LOL. More like the Pennycillin of the 21st Century. Under your scenario, the book you are hoping to read will most likely be in the Fantasy genre. Realistically, if there were a Train-Wreck genre, IPIX and Ehrlich would fit right in.
Not strange at all - Kevetrin Dead. Prurisol. Dead. B for Covid. Dead. Company infrastructure. Dead. Can you point out where any of the IPIX pipeline has passed the all important phase 3? We all know the IPIX history - a history of failure. If there were any major successes, this would not be trading in the dead zone. If the science were so great, this fools gold would not be consistently floating in the penny range. If the science were as promising as you believe it to be, partners would be knocking down Ehrlich's virtual door. Instead, there is a ghost town company operating on fumes which should run out soon....
The graveyard of the IPIX pipeline...humans.
.02 a share. I'd guess absolutely nothing.
$1.50 or more a share??? LOL. You keep saying the science is good but to date, all of these junk drugs sound great and promising in the early stages but ultimately fail where it counts most...in human trials that would enable the drug to make it to market. Check out the press releases from 2010 on (if you can find them since the Ehrlich website cleanse) and see how Ehrlich boasts about his once prized pipeline based on early stage results. And look at Ehrlich's once prized pipeline now. All failures...Prurisol. Kevetrin. B for Covid. Alfasigma moving at a snails pace on B. Here is a fact rather than an opinion- IPIX and its "prized" assets are worth less than .02 a share.
Welcome to Fantasy Island...
Definitely a better formula than P + K + B (to the Covid Power) = F
What good are all these press releases touting the benefits of an IPIX drug when nothing ever materializes. What exactly has been done since that study was referenced NINE years ago?
Maybe a comparison of what IPIX could look like if it had a competent CEO, a seemingly solid group of officers and employees, a non-comical infrastructure, real products,......
Maybe they can raise the ask to $1 or more to “stimulate a little interest.” And I always thought the market was based on supply and demand. In the case of IPIX, as you can tell from the pathetic daily volume and lack of buyer interest, there is virtually no demand.
Pink Sheet Leo has just enough cash to pay the salaries for himself and his stooge. Consequently, the last of his once prized pipeline is in the hands of others...so he just sits and waits. Could be years, if at all.
If this thing went up a penny for every patent Pink Sheet Leo filed and every hyped-up press release that is big on hope and absent on delivery, this garbage pit would be well over a dollar a share.
Too bad Ehrlich’s hype/enthusiasm isn’t shared by the market.
What is so positive about Ehrlich and what is left of his ghost town? Under his failed leadership, the stock price has disintegrated from almost $5 a share to almost nothing, his once hyped pipeline has turned to rust, there is virtually little money left, the "gem" recently dropped to the lowly pink sheets with no explanation form Ehrlich, hardly any trading volume...and yet the CEO and his stooge continue to get paid an enormous salary. Hope and hype that never materializes is all this carcass provides. Nothing but negativity surrounding this company.
If "[M]any people in the world know the Brilacidin name and potential. More every day," why is Pink Sheet Leo's one-man show trading at a penny a share? Why is there so little volume? Why does everything Ehrlich touch ultimately fail?
Three beeps do not count as "no phone problem." Pink Sheet Leo's phone was about as effective as his failing company.
At this point, a coconut would be an improvement.
Other than Ehrlich and his sidekick Just Pay Me Jane, we’ve heard about some bookkeeping person but whether that person remains at the ghost town today is a questionable.
The two stooges grab almost a million a year in salary. What will they do when the annual salary machine is empty?
And it will be many more years of wondering….Alfasigma B nothing but delays, B for Covid, major fail, the rest - if the light of day is ever seen, years away. B the Wonder Drug.
Good eye. These blurbs could at least get the facts straight.
Everything Ehrlich was involved in - according to him - presented monster opportunities, none of which panned out. With less than $2 million on hand to service this broken down clunker by way of caretaker salary drain, perhaps his reliance on an outside product where his influence is - hopefully - nonexistent, will pay off.
Since Pivot to the Beam Ehrlich’s once promising pipeline is a disaster, this failing one-man operation has little more than its $4 million/$72 a share investment to rely on. If that gamble fails, no more salary machine for Leo and his stooge.
B is like a student who studies all the time but when it comes to taking the final exam, fails. Keep those studies coming.
Even the flies won’t come around this mess. Pronounced dead companies have more trading volume.
I have my finger on the bye button...now if Ehrlich was gone, maybe....
LOL. So instead of buying out this ghost town company or licensing the wonder drug, all these BP companies have gotten together to conspire against IPIX and its dimwitted CEO? Did they also conspire to do in Prurisol? And Kevetrin. And B for Covid? Did they shut down the company phone for several days? Did they pay off Locust Walk and the Payer Analyst to diminish the IPIX attractiveness factor? Did they also divert Leo so he let the Beverly Lease slip by and lost track of the Nevada registration? Did they somehow convince Ehrlich that dropping to the Pink Sheets was in the best interest of the company and shareholders?
That would explain the high volume (5000 shares traded) for IPIX this morning.....